Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Increased EZH2 and decreased osteoblastogenesis during local irradiation-induced bone loss in rats.

Guo C, Li C, Yang K, Kang H, Xu X, Xu X, Deng L.

Sci Rep. 2016 Aug 8;6:31318. doi: 10.1038/srep31318.

2.

DNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity.

Wang Y, Sun H, Wang J, Wang H, Meng L, Xu C, Jin M, Wang B, Zhang Y, Zhang Y, Zhu T.

Cell Death Dis. 2016 Jul 28;7(7):e2316. doi: 10.1038/cddis.2016.198.

3.

Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion.

Loupe JM, Miller PJ, Bonner BP, Maggi EC, Vijayaraghavan J, Crabtree JS, Taylor CM, Zabaleta J, Hollenbach AD.

Oncogenesis. 2016 Jul 25;5(7):e246. doi: 10.1038/oncsis.2016.53.

4.

LATS2 Positively Regulates Polycomb Repressive Complex 2.

Torigata K, Daisuke O, Mukai S, Hatanaka A, Ohka F, Motooka D, Nakamura S, Ohkawa Y, Yabuta N, Kondo Y, Nojima H.

PLoS One. 2016 Jul 19;11(7):e0158562. doi: 10.1371/journal.pone.0158562. eCollection 2016.

5.

Polycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular background.

Gall Trošelj K, Novak Kujundzic R, Ugarkovic D.

Clin Epigenetics. 2016 May 27;8:55. doi: 10.1186/s13148-016-0226-1. eCollection 2016. Review.

6.

Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice.

Zhang P, Xing C, Rhodes SD, He Y, Deng K, Li Z, He F, Zhu C, Nguyen L, Zhou Y, Chen S, Mohammad KS, Guise TA, Abdel-Wahab O, Xu M, Wang QF, Yang FC.

Stem Cell Reports. 2016 Jun 14;6(6):914-25. doi: 10.1016/j.stemcr.2016.04.013. Epub 2016 May 26.

7.

Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.

Hemming S, Cakouros D, Vandyke K, Davis MJ, Zannettino AC, Gronthos S.

Stem Cells Dev. 2016 Jun 15;25(12):909-21. doi: 10.1089/scd.2015.0384. Epub 2016 Jun 7.

PMID:
27168161
8.

Role of EZH2 histone methyltrasferase in melanoma progression and metastasis.

Mahmoud F, Shields B, Makhoul I, Hutchins LF, Shalin SC, Tackett AJ.

Cancer Biol Ther. 2016 Jun 2;17(6):579-91. doi: 10.1080/15384047.2016.1167291. Epub 2016 Apr 22.

PMID:
27105109
9.

Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1.

Lin Z, Tan C, Qiu Q, Kong S, Yang H, Zhao F, Liu Z, Li J, Kong Q, Gao B, Barrett T, Yang GY, Zhang J, Fang D.

Cell Discov. 2015;1. pii: 15028. Epub 2015 Oct 13.

10.

Epigenetic Mechanisms Regulating Mesenchymal Stem Cell Differentiation.

Pérez-Campo FM, Riancho JA.

Curr Genomics. 2015 Dec;16(6):368-83. doi: 10.2174/1389202916666150817202559.

11.

Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.

Roesley SN, Suryadinata R, Morrish E, Tan AR, Issa SM, Oakhill JS, Bernard O, Welch DR, Šarčević B.

Cell Cycle. 2016;15(1):137-51. doi: 10.1080/15384101.2015.1121328.

PMID:
26771717
12.
13.

Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.

Kikuchi J, Koyama D, Wada T, Izumi T, Hofgaard PO, Bogen B, Furukawa Y.

J Clin Invest. 2015 Oct 26;125(12):4375-90. doi: 10.1172/JCI80325.

14.

Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.

Jung YS, Jun S, Lee SH, Sharma A, Park JI.

Oncotarget. 2015 Nov 10;6(35):37257-68. doi: 10.18632/oncotarget.6133.

15.

Epigenetic Control of the Bone-master Runx2 Gene during Osteoblast-lineage Commitment by the Histone Demethylase JARID1B/KDM5B.

Rojas A, Aguilar R, Henriquez B, Lian JB, Stein JL, Stein GS, van Wijnen AJ, van Zundert B, Allende ML, Montecino M.

J Biol Chem. 2015 Nov 20;290(47):28329-42. doi: 10.1074/jbc.M115.657825. Epub 2015 Oct 9.

PMID:
26453309
16.

Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.

Dudakovic A, Camilleri ET, Xu F, Riester SM, McGee-Lawrence ME, Bradley EW, Paradise CR, Lewallen EA, Thaler R, Deyle DR, Larson AN, Lewallen DG, Dietz AB, Stein GS, Montecino MA, Westendorf JJ, van Wijnen AJ.

J Biol Chem. 2015 Nov 13;290(46):27604-17. doi: 10.1074/jbc.M115.672345. Epub 2015 Sep 30.

PMID:
26424790
17.

The decrease in histone methyltransferase EZH2 in response to fluid shear stress alters endothelial gene expression and promotes quiescence.

Maleszewska M, Vanchin B, Harmsen MC, Krenning G.

Angiogenesis. 2016 Jan;19(1):9-24. doi: 10.1007/s10456-015-9485-2. Epub 2015 Sep 28.

18.

Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis.

Jing H, Liao L, An Y, Su X, Liu S, Shuai Y, Zhang X, Jin Y.

Mol Ther. 2016 Feb;24(2):217-29. doi: 10.1038/mt.2015.152. Epub 2015 Aug 26.

PMID:
26307668
19.

Histone demethylase JMJD3 is required for osteoblast differentiation in mice.

Zhang F, Xu L, Xu L, Xu Q, Karsenty G, Chen CD.

Sci Rep. 2015 Aug 25;5:13418. doi: 10.1038/srep13418.

20.

Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.

Yang CC, LaBaff A, Wei Y, Nie L, Xia W, Huo L, Yamaguchi H, Hsu YH, Hsu JL, Liu D, Lang J, Du Y, Lien HC, Li LY, Deng R, Chan LC, Yao J, Kleer CG, Hortobagyi GN, Hung MC.

Am J Transl Res. 2015 Jun 15;7(6):1009-20. eCollection 2015.

Items per page

Supplemental Content

Write to the Help Desk